Actively Recruiting

Phase 3
Age: 18Years - 74Years
All Genders
NCT06775379

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

Led by Xenon Pharmaceuticals Inc. · Updated on 2025-10-22

450

Participants Needed

46

Research Sites

92 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

X-NOVA2 is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of azetukalner as a monotherapy in adult participants diagnosed with Major Depressive Disorder (MDD)

CONDITIONS

Official Title

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

Who Can Participate

Age: 18Years - 74Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults 18 to 74 years of age who experienced their first major depressive episode before age 50
  • Body Mass Index (BMI) of 40 kg/m2 or less
  • Meets DSM-5-TR criteria for current major depressive disorder and is currently in a major depressive episode confirmed by MINI
  • Current major depressive episode lasting between 6 weeks and 24 months
Not Eligible

You will not qualify if you...

  • Primary diagnosis of a mood disorder other than major depressive disorder
  • History of MDD with psychotic or catatonic features, MDD with mixed features, Bipolar I or II disorder, obsessive-compulsive disorder, schizophrenia, primary thought disorder, or other psychotic disorders
  • Current diagnosis of MDD with seasonal pattern, depression with peripartum or perimenopausal onset, post traumatic stress disorder, antisocial or borderline personality disorder, panic disorder and/or agoraphobia, ADHD treated with a psychostimulant or unstable symptoms
  • Substance (excluding tobacco) or alcohol use disorder within 12 months prior to screening
  • Active suicidal plan or intent within 6 months prior to screening, suicidal behavior in last 2 years, or more than 1 suicide attempt after age 24
  • History of non-suicidal self-harm behavior in 12 months prior to screening
  • Use of antidepressants or prohibited medications within 2 weeks (4 weeks for fluoxetine) or less than 5 times the drug's half-life before randomization
  • History of non-response to 2 or more antidepressant drugs of adequate dose and duration in current major depressive episode
  • Medical conditions that may interfere with study conduct or purpose
  • Pregnant, breastfeeding, or planning pregnancy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 46 locations

1

IMA Clinical Research Phoenix

Phoenix, Arizona, United States, 85012

Actively Recruiting

2

Woodland International Research Group

Little Rock, Arkansas, United States, 72211

Actively Recruiting

3

Woodland Research Northwest

Rogers, Arkansas, United States, 72758

Actively Recruiting

4

Behavioral Research Specialists, Llc

Glendale, California, United States, 91206

Actively Recruiting

5

Marvel Clinical Research

Huntington Beach, California, United States, 92647

Actively Recruiting

6

Irvine Clinical Research

Irvine, California, United States, 92614

Actively Recruiting

7

CalNeuro Research Group, Inc.

Los Angeles, California, United States, 90025

Actively Recruiting

8

Excell Research Inc.

Oceanside, California, United States, 92056

Actively Recruiting

9

Atp Clinical Research

Orange, California, United States, 92866

Actively Recruiting

10

Nrc Research Institute

Orange, California, United States, 92868

Actively Recruiting

11

CenExel CNS-TO (Collaborative Neuroscience Research)

Torrance, California, United States, 90504

Actively Recruiting

12

Sunwise Clinical Research

Walnut Creek, California, United States, 94596

Actively Recruiting

13

Ct Clinical Research Associates

Cromwell, Connecticut, United States, 06416

Actively Recruiting

14

CNS Clinical Research Group

Coral Springs, Florida, United States, 33067

Actively Recruiting

15

NeoClinical Research

Hialeah, Florida, United States, 33016

Actively Recruiting

16

Clinical Neuroscience Solutions, Inc.

Jacksonville, Florida, United States, 32256

Actively Recruiting

17

Accel Research Sites Lakeland

Lakeland, Florida, United States, 33803

Actively Recruiting

18

Accel Research Sites - St. Petersburg-Largo

Largo, Florida, United States, 33777

Actively Recruiting

19

PharmaSouth Research

Miami, Florida, United States, 33165

Actively Recruiting

20

Quantum Clinical Trials

Miami Beach, Florida, United States, 33140

Terminated

21

Harmony Clinical Research Inc

North Miami Beach, Florida, United States, 33162

Actively Recruiting

22

Clinical Neuroscience Solutions, Inc.

Orlando, Florida, United States, 32801

Actively Recruiting

23

Combined Research Orlando Phase I-Iv

Orlando, Florida, United States, 32807

Actively Recruiting

24

Panhandle Research and Medical Clinic

Pensacola, Florida, United States, 32503

Actively Recruiting

25

Advanced Discovery Research

Atlanta, Georgia, United States, 30318

Actively Recruiting

26

Synexus - Atlanta

Atlanta, Georgia, United States, 30328

Actively Recruiting

27

CenExel iResearch

Decatur, Georgia, United States, 30030

Actively Recruiting

28

Psych Atlanta, Pc

Marietta, Georgia, United States, 30060

Actively Recruiting

29

Cenexel Iresearch - Savannah

Savannah, Georgia, United States, 31405

Actively Recruiting

30

Northwest Clinical Trials Inc

Boise, Idaho, United States, 83704

Actively Recruiting

31

Chicago Research Center Inc.

Chicago, Illinois, United States, 60634

Actively Recruiting

32

Boston Clinical Trials Llc

Boston, Massachusetts, United States, 02131

Actively Recruiting

33

ELIXIA

Springfield, Massachusetts, United States, 01103

Actively Recruiting

34

IMA Clinical Research Las Vegas

Las Vegas, Nevada, United States, 89102

Actively Recruiting

35

Redbird Research

Las Vegas, Nevada, United States, 89119

Actively Recruiting

36

IMA Clinical Research

Albuquerque, New Mexico, United States, 87109

Actively Recruiting

37

Integrative Clinical Trials

Brooklyn, New York, United States, 11229

Actively Recruiting

38

Richmond Behavioral Associates

Staten Island, New York, United States, 10314

Actively Recruiting

39

New Hope Clinical Research

Charlotte, North Carolina, United States, 28211

Actively Recruiting

40

Pahl Pharmaceutical Professionals Llc

Oklahoma City, Oklahoma, United States, 73112

Actively Recruiting

41

Lehigh Center For Clinical Research

Allentown, Pennsylvania, United States, 18103

Actively Recruiting

42

Clinical Neuroscience Solutions, Inc.

Memphis, Tennessee, United States, 38119

Actively Recruiting

43

Delricht Research - Plano

Plano, Texas, United States, 75024

Actively Recruiting

44

Aim Trials, Llc

Plano, Texas, United States, 75093

Actively Recruiting

45

Grayline Research Center

Wichita Falls, Texas, United States, 76309

Actively Recruiting

46

Core Clinical Research

Everett, Washington, United States, 98201

Actively Recruiting

Loading map...

Research Team

X

Xenon Medical Affairs

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder | DecenTrialz